FDA Approves Ravulizumab for Paroxysmal Nocturnal Hemoglobinuria

Schuyler, D

CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019; 17 (1): 67

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索